Management and prognosis of malignant peripheral nerve sheath tumors : The experience of the French Sarcoma Group (GSF-GETO). European Journal of Cancer (Oxford, England : 1990), 56 : 77-84, 2016.Valentin T, Le Cesne A, Ray-Coquard I et al. Manage- ment and prognosis of ...
Compte rendu de la réunion annuelle du GSF-GETO, Nice 11 au 14 octobre 2006New friction couples, initially intended to limit osteolysis risk due to debris, have enabled larger implant head diameters to be developed to resolve the problem of hip implant dislocation. The Symposium demonstrated ...
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)dagger. Ann Oncol 2015; 26: 2168-2173.Bompas E, Le Cesne A, Tresch-Bruneel E et al (2015) Sorafenib in patients with locally advanced and metastatic chordomas:...
L., ChaigneauLindet C, Neuville A, Penel N, et al. Localised angiosarcomas : The identification of prognostic factors and analysis of treatment im- pact. A retrospective analysis from the French Sarcoma Group (GSF/GETO) [J]. Eur J Cancer,2013,49(2) :369 -376....